Correction: Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes.

Huiqin Chen, Yuan Li, Qiaofeng Shen, Guanqun Guo, Zhigang Wang, Hanyu Pan, Min Wu, Xueqing Yan, Gen Yang

Abstract readPublished Erratum

In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Catalpol Reactivates IL-7R-STAT5 Signaling and Reverses Radiation-Induced T Helper 1 Cells Deficiency to Limit Melanoma Metastasis to Lung.Integrative cancer therapies
Article

4 · The record

Corrections and comments

Erratum for
Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes.2024

5 · Who and what money

Authors and funding

9 authors.

Huiqin ChenState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Yuan LiState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Qiaofeng ShenWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.

Guanqun GuoState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Zhigang WangState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Hanyu PanState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Min WuState Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, China.

Xueqing YanOncology Discipline Group, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325003, China.

Gen YangOncology Discipline Group, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325003, China. gen.yang@pku.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41184782

DOI10.1186/s10020-025-01382-4

PMCPMC12584475

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.